Search Results

Displaying Results 426-450 of 490 "'SCI'"

Oct 14, 2025, 08:30 ET Kyoto University Engineering Ph.D. Team Achieves Technology Transformation in Chengdu; LivingPhoenix's Biomimetic Collagen Rated "International Leading-Edge"

author. Contributors included Lu Nan, Dr. Takafumi Takebayashi, Dr. Zhou Boyu, and Xie Hongbin. The related peer-reviewed paper was published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology in April 2025. The paper concluded that the biomimetic collagen component is safe, structurally

More news about: LivingPhoenix


Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics

[5] Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. [6] Morris JC. Neurology.

More news about: BioArctic


Oct 13, 2025, 07:15 ET AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors

Shalata W, Naamneh R, Najjar W, et al. Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung Cancer. Med Sci. 2025; 13(3):142. doi:10.3390/medsci13030142 Daamen LA, Molenaar IQ, and Groot VP. Recent Advances and Future Challenges

More news about: AbbVie


Oct 11, 2025, 08:17 ET Haileybury Astana eröffnet hochmodernes wissenschaftlich-technisches Zentrum in Astana

-- Haileybury Astana, eine führende britische internationale Schule in Kasachstan unter der Leitung von Schulleiter John Coles, hat offiziell das Sci-Tech-Hub eröffnet – ein Bildungszentrum der nächsten Generation, welches Wissenschaft, Technologie, Ingenieurwesen und Mathematik (MINT) in einem interdisziplinären

More news about: The Bulat Utemuratov Foundation


Oct 11, 2025, 08:11 ET Haileybury Astana inaugure un centre scientifique et technologique de pointe à Astana

-- Haileybury Astana, une école internationale britannique de premier plan au Kazakhstan dirigée par le directeur John Coles, a officiellement ouvert le Sci-Tech Hub - un centre éducatif de nouvelle génération qui intègre l'apprentissage des sciences, de la technologie, de l'ingénierie et des mathématiques

More news about: The Bulat Utemuratov Foundation


Oct 10, 2025, 13:30 ET "JIM HENSON'S MONSTER DANCE," THE JIM HENSON COMPANY'S NEW ANIMATED SERIES OF SHORTS FOR AMAZON KIDS+, ROARS INTO PRODUCTION

series The Dark Crystal: Age of Resistance, both for Netflix. Iconic catalogue titles include Fraggle Rock, The Storyteller, the sci-fi series Farscape, and the ground-breaking fantasy classics The Dark Crystal and Labyrinth. Headquartered

More news about: The Jim Henson Company


Oct 10, 2025, 12:53 ET New Study Showed Unnecessary Burden From Continued Monitoring of Alloimmunized Pregnancies With Antigen-Negative Fetuses

Cantonwine DE, McElrath TF, Carozza JA, Wynn J, Hoskovec J, Gray KJ. Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fya antigens. Sci Rep. 2023 Aug 7;13(1):12786. doi: 10.1038/s41598-023-39283-3. PMID: 37550335; PMCID: PMC10406947.

More news about: BillionToOne


Oct 10, 2025, 10:22 ET Haileybury Astana Opens State-of-the-Art Sci-Tech Hub in Astana

The Sci-Tech Hub was completed in a record 10 months, with a total investment of KZT 3.4 billion provided by Verny Capital. Aidan Akanov, CEO of Verny Capital, said: "The Sci-Tech Hub is

More news about: The Bulat Utemuratov Foundation


Oct 10, 2025, 10:17 ET Haileybury Astana Opens State-of-the-Art Sci-Tech Hub in Astana

The Sci-Tech Hub was completed in a record 10 months, with a total investment of KZT 3.4 billion provided by Verny Capital. Aidan Akanov, CEO of Verny Capital, said: "The Sci-Tech Hub is

More news about: The Bulat Utemuratov Foundation


Oct 09, 2025, 11:30 ET Gold Hits $4,000 As Miner Funds Post Best Year Since 1979

been approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific

More news about: Equity Insider


Oct 09, 2025, 07:52 ET Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models

et al. Chloroindazole based estrogen receptor β ligands with favorable pharmacokinetics promote functional remyelination and visual recovery. Sci Rep15, 35056 (2025).

More news about: Cadenza Bio, Inc.


Oct 07, 2025, 10:00 ET Kevin Schewe's "Bad Love Strikes" Wins Best Feature Screenplay at the Tokyo International CINEVERSE Screenplay Awards!

big screen—2025 is the year to come alive!" Dr. Schewe celebrates. Whether you're a history aficionado, a time-travel buff, a sci-fi lover, or just in need of a fun book series, to cheer you up, the Bad Love Book series is the adventure you've been waiting for.

More news about: Kevin L. Schewe


Oct 06, 2025, 18:05 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

[5] Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. [6] Morris JC. Neurology.

More news about: BioArctic


Oct 06, 2025, 18:02 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.

[5] Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. [6] Morris JC. Neurology.

More news about: BioArctic


Oct 06, 2025, 16:30 ET Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease

Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. Morris JC. Neurology. 1993;43(11):2412-4.

More news about: Eisai Inc.


Oct 03, 2025, 08:33 ET SSFF & ASIA 2025 will host AI International Conference at Screening in Autumn

ethical dimensions of AI in film production. In addition, the festival will host the Asia Premiere of "IMPERIA", a 36-minute sci-fi AI short film by Marcel Barsotti, a renowned composer and filmmaker. As both a composer and director, Barsotti will discuss how leveraging AI enabled

More news about: Short Shorts Film Festival & Asia


Oct 02, 2025, 03:23 ET Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025

2020;17:1582–1602. Mészáros L, et al. Int J Mol Sci. 2020;21:2775. Kidwell KM, et al. Orphanet J Rare Dis. 2022 May 7;17(1):186 Garczarek U, et al. Ther Innov Regul Sci. 2023 May;57(3):445-452

More news about: H. Lundbeck A/S


Oct 02, 2025, 03:20 ET Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025

2020;17:1582–1602. Mészáros L, et al. Int J Mol Sci. 2020;21:2775. Kidwell KM, et al. Orphanet J Rare Dis. 2022 May 7;17(1):186 Garczarek U, et al. Ther Innov Regul Sci. 2023 May;57(3):445-452

More news about: H. Lundbeck A/S


Oct 01, 2025, 11:45 ET Gold Breaks $3,800 as Institutions Turn to Junior Miners

been approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific

More news about: USA News Group


Oct 01, 2025, 11:15 ET Gold Surges Past $3,800 as Institutions Eye Junior Mining Opportunity

been approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific

More news about: Equity Insider


Sep 29, 2025, 16:15 ET Third Coast Bancshares, Inc. Recognized by Structured Credit Investor (SCI) as "2025 North American Issuer of the Year" and "2025 North American Transaction of the Year" Finalists

Third Coast Bancshares, Inc. (the "Company") (NASDAQ: TCBX) announced today that it has been nominated as the 2025 North American Issuer of the Year by SCI, in recognition of the Company's landmark securitizations executed in 2025 and its leadership in risk management innovation within the regional banking

More news about: Third Coast Bancshares


Sep 29, 2025, 04:52 ET VC Community Convenes in Qingdao to Explore New Financial Landscape Amid 2025 Qingdao Venture Capital Conference

to explore new funding sources, support pilots for equity investment by Asset Investment Companies (AICs), and empower private fund managers to issue Sci-Tech innovation bonds; on investment, it's introducing guidance for high-quality development of government investment funds and progressively implementing

More news about: 2025 Qingdao Venture Capital Conference


Sep 29, 2025, 02:38 ET Leqembi® approved for IV maintenance treatment in China

[iv] Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. This information was brought to you by Cision

More news about: BioArctic


Sep 29, 2025, 02:34 ET Leqembi® approved for IV maintenance treatment in China

[iv] Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. This information was brought to you by Cision

More news about: BioArctic


Sep 27, 2025, 03:08 ET Science fiction writer Liu Cixin dissects the popularity of his epic work

modestly attributed its global success to two main aspects. He dismissed the idea that its global appeal lies in providing a sci-fi perspective on China. Instead, he says, the novel's success stems from its offering of a panoramic depiction of the arrival

More news about: chinadaily.com.cn


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.